479 related articles for article (PubMed ID: 32440115)
21. Delivery of paeonol by nanoparticles enhances its in vitro and in vivo antitumor effects.
Chen C; Jia F; Hou Z; Ruan S; Lu Q
Int J Nanomedicine; 2017; 12():6605-6616. PubMed ID: 28924345
[TBL] [Abstract][Full Text] [Related]
22. An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel.
Xie H; Li L; Sun Y; Wang Y; Gao S; Tian Y; Ma X; Guo C; Bo F; Zhang L
Nanomaterials (Basel); 2019 Jan; 9(2):. PubMed ID: 30682799
[TBL] [Abstract][Full Text] [Related]
23. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
[TBL] [Abstract][Full Text] [Related]
24. PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU.
He RX; Ye X; Li R; Chen W; Ge T; Huang TQ; Nie XJ; Chen HJ; Peng DY; Chen WD
J Liposome Res; 2017 Jun; 27(2):161-170. PubMed ID: 27184460
[TBL] [Abstract][Full Text] [Related]
25. Controlled SLN Delivery by Thermoresponsive In-situ Forming Erodible Gels; A Whole-body and Organ Imaging Study.
Dorraj G; Dadashzadeh S; Erfan M; Moghimi HR
Curr Drug Deliv; 2018; 15(4):510-519. PubMed ID: 29422000
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
[TBL] [Abstract][Full Text] [Related]
27. Paeonol-loaded PLGA nanoparticles as an oral drug delivery system: Design, optimization and evaluation.
Wang F; Shan Q; Chang X; Li Z; Gui S
Int J Pharm; 2021 Jun; 602():120617. PubMed ID: 33887394
[TBL] [Abstract][Full Text] [Related]
28. PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide.
Al-Zuhairy SAS; Teaima MH; Shoman NA; Elasaly M; El-Nabarawi MA; El-Sawy HS
Drug Deliv; 2023 Dec; 30(1):2189112. PubMed ID: 36916128
[TBL] [Abstract][Full Text] [Related]
29. Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment.
Jain AK; Jain A; Garg NK; Agarwal A; Jain A; Jain SA; Tyagi RK; Jain RK; Agrawal H; Agrawal GP
Colloids Surf B Biointerfaces; 2014 Sep; 121():222-9. PubMed ID: 25016424
[TBL] [Abstract][Full Text] [Related]
30. Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies.
Farsani PA; Mahjub R; Mohammadi M; Oliaei SS; Mahboobian MM
Biomed Res Int; 2021; 2021():6619195. PubMed ID: 33997026
[TBL] [Abstract][Full Text] [Related]
31. Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington's disease.
Bhatt R; Singh D; Prakash A; Mishra N
Drug Deliv; 2015; 22(7):931-9. PubMed ID: 24512295
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers.
Chen ZX; Li B; Liu T; Wang X; Zhu Y; Wang L; Wang XH; Niu X; Xiao Y; Sun Q
Eur J Pharm Sci; 2017 Mar; 99():240-245. PubMed ID: 28039091
[TBL] [Abstract][Full Text] [Related]
33. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
[TBL] [Abstract][Full Text] [Related]
34. Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin.
Li C; Zhou K; Chen D; Xu W; Tao Y; Pan Y; Meng K; Shabbir MAB; Liu Q; Huang L; Xie S
Int J Nanomedicine; 2019; 14():1619-1631. PubMed ID: 30880969
[TBL] [Abstract][Full Text] [Related]
35. Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.
Nazief AM; Hassaan PS; Khalifa HM; Sokar MS; El-Kamel AH
Int J Nanomedicine; 2020; 15():1129-1148. PubMed ID: 32110012
[TBL] [Abstract][Full Text] [Related]
36. Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin.
Fahmy UA; Ahmed OAA; Badr-Eldin SM; Aldawsari HM; Okbazghi SZ; Awan ZA; Bakhrebah MA; Alomary MN; Abdulaal WH; Medina C; Alhakamy NA
Int J Nanomedicine; 2020; 15():5253-5264. PubMed ID: 32801690
[TBL] [Abstract][Full Text] [Related]
37. Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression.
He X; Zhu Y; Wang M; Jing G; Zhu R; Wang S
Int J Nanomedicine; 2016; 11():4975-4990. PubMed ID: 27757031
[TBL] [Abstract][Full Text] [Related]
38. β-Hydroxybutyric acid grafted solid lipid nanoparticles: a novel strategy to improve drug delivery to brain.
Venishetty VK; Samala R; Komuravelli R; Kuncha M; Sistla R; Diwan PV
Nanomedicine; 2013 Apr; 9(3):388-97. PubMed ID: 22960191
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
40. Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability.
Kang X; Chen H; Li S; Jie L; Hu J; Wang X; Qi J; Ying X; Du Y
Colloids Surf B Biointerfaces; 2018 Jan; 161():597-605. PubMed ID: 29156336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
